We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-3.84%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$6.16B
AUM Growth
+$1.7B
Cap. Flow
+$2.17B
Cap. Flow %
35.15%
Top 10 Hldgs %
26.62%
Holding
7,028
New
630
Increased
3,221
Reduced
2,151
Closed
574

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$204M
2
MSFT icon
Microsoft
MSFT
+$195M
3
AMZN icon
Amazon
AMZN
+$97.4M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$95M
5
TSM icon
TSMC
TSM
+$69.5M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$53M
2
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$26.7M
3
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$23.7M
4
IWD icon
iShares Russell 1000 Value ETF
IWD
+$19.5M
5
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$15M

Sector Composition

Rank Sector Weight
1 Technology 26.99%
2 Healthcare 10.86%
3 Consumer Discretionary 10.71%
4 Financials 8.62%
5 Communication Services 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VPL icon
4701
Vanguard FTSE Pacific ETF
VPL
$8.65B
$9K ﹤0.01%
147
+82
+126% +$5.24K
VSTA
4702
DELISTED
Vasta Platform
VSTA
$9K ﹤0.01%
+1,720
New +$8.93K
VVOS icon
4703
Vivos Therapeutics
VVOS
$4.24M
$9K ﹤0.01%
531
+391
+279% +$11.9K
WVVI icon
4704
Willamette Valley Vineyards
WVVI
$12M
$9K ﹤0.01%
1,578
+659
+72% +$4.16K
XBIT icon
4705
XBiotech
XBIT
$75M
$9K ﹤0.01%
2,571
-28,057
-92% -$132K
XPL icon
4706
Solitario Resources
XPL
$73.6M
$9K ﹤0.01%
17,970
+2,574
+17% +$1.4K
XTNT icon
4707
Xtant Medical Holdings
XTNT
$43.5M
$9K ﹤0.01%
11,914
+988
+9% +$541
ONIT
4708
Onity Group
ONIT
$321M
$9K ﹤0.01%
389
+379
+3,790% +$11K
RIME
4709
Algorhythm Holdings
RIME
$6.98M
$9K ﹤0.01%
+8
New +$12.3K
CIRC
4710
Circle8 Group
CIRC
$61.2M
$9K ﹤0.01%
317
+144
+83% +$5.31K
IPM
4711
Intelligent Protection Management Corp
IPM
$24.9M
$9K ﹤0.01%
6,253
+2,384
+62% +$4.29K
CYTH
4712
DELISTED
Cyclo Therapeutics, Inc. Common Stock
CYTH
$9K ﹤0.01%
4,580
+2,310
+102% +$4.84K
VIRX
4713
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$9K ﹤0.01%
2,145
+1,237
+136% +$5.24K
KACL
4714
DELISTED
Kairous Acquisition Corp. Limited Ordinary Shares
KACL
$9K ﹤0.01%
909
-159
-15% -$1.59K
WHLM
4715
DELISTED
Wilhelmina International, Inc
WHLM
$9K ﹤0.01%
+2,241
New +$10.2K
PGRU
4716
DELISTED
PropertyGuru Group Limited
PGRU
$9K ﹤0.01%
1,924
+356
+23% +$1.69K
AUGX
4717
DELISTED
Augmedix, Inc. Common Stock
AUGX
$9K ﹤0.01%
6,458
-980
-13% -$1.68K
CVIIU
4718
DELISTED
Churchill Capital Corp VII Units
CVIIU
$9K ﹤0.01%
929
– –
VBIV
4719
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$9K ﹤0.01%
406
-412
-50% -$11.1K
EFTR
4720
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$9K ﹤0.01%
656
+357
+119% +$7K
ISUN
4721
DELISTED
iSun, Inc. Common Stock
ISUN
$9K ﹤0.01%
+3,895
New +$12K
AMJ
4722
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$9K ﹤0.01%
441
+188
+74% +$3.94K
TRVN
4723
DELISTED
Trevena, Inc.
TRVN
$9K ﹤0.01%
+92
New +$14.1K
AWH
4724
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$9K ﹤0.01%
1,662
+1,416
+576% +$15.2K
ID
4725
DELISTED
PARTS iD, Inc.
ID
$9K ﹤0.01%
5,816
+2,383
+69% +$3.01K
187 188
189
190 191

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2022 Portfolio in Review

As of Q3 2022, Tower Research Capital (TRC) held 7,028 positions worth $6.16B, up 38% from $4.46B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $2.17B of net new capital in Q3 2022, opening 630 new positions and adding to 3,221 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $53M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2022 buy was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.
  • Tower Research Capital (TRC) added most to Apple in Q3 2022, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $53M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Portfolio S&P 500 ETF in Q3 2022, selling an estimated $6.39M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $6.16B portfolio in Q3 2022.
  • Tower Research Capital (TRC) opened 630 new positions and closed 574 in Q3 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 38% quarter-over-quarter to $6.16B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2022, filed 10 Nov 2022.